SCIWIND BIOSCIENCES
Sciwind Biosciences is a developers of drugs intended to treat metabolic disorders. The company's drugs contain protein and peptide candidates for non-alcoholic steatohepatitis, enabling physicians to treat their patients in an enhanced way.
SCIWIND BIOSCIENCES
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.sciwind.com.cn
Total Employee:
51+
Status:
Active
Total Funding:
136.34 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Mobile Non Scaleable Content Euro Microsoft Azure DNS DigiCert SSL Pound Sterling Japanese Yen
Similar Organizations
LYNK Pharmaceuticals
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.
Rising BioSciences
Rising BioSciences is a research and development company focusing on oral and topical cannabis based pharmaceuticals.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Teligene
Teligene is a drug discovery company edicating to developing innovative small-molecule drugs.
Yidao Biotechnology
Yidao Biotechnology research and develops vaccines and biomedical products.
Current Employees Featured
Founder
Investors List
LYFE Capital
LYFE Capital investment in Series C - Sciwind Biosciences
Zhengxingu Capital
Zhengxingu Capital investment in Series C - Sciwind Biosciences
Loyal Valley Capital
Loyal Valley Capital investment in Series C - Sciwind Biosciences
IDG Capital
IDG Capital investment in Series C - Sciwind Biosciences
Legend Capital
Legend Capital investment in Series B - Sciwind Biosciences
LYFE Capital
LYFE Capital investment in Series B - Sciwind Biosciences
Haibang Capital
Haibang Capital investment in Series B - Sciwind Biosciences
Legend Capital
Legend Capital investment in Series A - Sciwind Biosciences
Shiyu Capital
Shiyu Capital investment in Series A - Sciwind Biosciences
Kawin Technology
Kawin Technology investment in Series A - Sciwind Biosciences
Official Site Inspections
http://www.sciwind.com.cn
- Host name: 121.196.48.215
- IP address: 121.196.48.215
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Sciwind Biosciences"
先为达_杭州先为达生物科技股份有限公司
创新疗法 探索提高生命质量的可能. 先为达聚焦代谢疾病领域生物大分子新药研发，通过自主研发与合作开发双轮驱动，为患者提供治疗包括肥胖症、糖尿病和非酒精性脂肪性肝炎（nash）在内的多种代谢性疾病的创新大分子药物，竭尽我 …See details»
Sciwind
Sciwind Biosciences . Developing innovative therapies to treat metabolic disease . Our Strategy. We are a fast-growing clinical-stage biopharmaceutical company developing a portfolio of therapeutic candidates for metabolic disease. Our …See details»
Sciwind Biosciences - Crunchbase Company Profile & Funding
Www.sciwind.com.cn ; 24,150; Highlights. obfuscated. Total Funding Amount . Unlock for free . Contacts 4. Employee Profiles 4. Investors 8. Similar Companies 15. Recent News & Activity. …See details»
Leadership - Sciwind
Prior to founding Sciwind Biosciences, Dr. Pan held leadership roles at Amgen, as well as at China-based Kawin Biotech. Dr. Pan is an accomplished researcher with deep knowledge and …See details»
先为达_杭州先为达生物科技股份有限公司
管理团队. 深厚的专业背景、广阔的国际视野是先为达管理团队的特质。团队成员既有来自安进（Amgen）、礼来（Lilly）、吉利德（Gilead）、诺华（Novartis）、诺和诺德（Novo Nordisk）和葛兰素史克（GSK）等跨国企业 …See details»
先为达_杭州先为达生物科技股份有限公司
杭州先为达生物科技股份有限公司是聚焦危重代谢性疾病和生物免疫治疗药物的新型国际化生物医药企业，致力于具有自主知识产权全球首创或同类最佳生物创新药物的研究和开发。See details»
Sciwind Biosciences Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Sciwind Biosciences Co., Ltd. of Hangzhou, Zhejiang. Get the latest business insights from Dun & …See details»
Hangzhou Sciwind Biosciences Co Ltd - Company Profile and News
Company profile page for Hangzhou Sciwind Biosciences Co Ltd including stock price, company news, executives, board members, and contact informationSee details»
Sciwind Biosciences - LinkedIn
Sciwind Biosciences Biotechnology Research San Ramon, California 247 followers Sciwind Biosciences is a clinical-stage biopharmaceutical company focusing on novel drug discovery for metabolic diseaseSee details»
Contact - Sciwind
USA Headquarters. 3001 Bishop Drive, Suite 300 San Ramon, CA 94583, USA. [email protected]. [email protected]See details»
Sciwind Company Profile - Office Locations, Competitors ... - Craft
Sciwind has 1 employees across 2 locations and $66.5 m in total funding,. See insights on Sciwind including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
News & Partnerships - Sciwind
Sciwind Biosciences Completes $70 Million Series C Financing and Expands Leadership Team to Advance Metabolic Disease Pipeline. July 11, 2021. Sciwind Biosciences Appoints Dr. …See details»
Sciwind Biosciences - VentureRadar
"Xianweida is a science-driven international biomedical company, focusing on the research and development of new biomacromolecule drugs in the fields of liver metabolic diseases and lung …See details»
XW-017 - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 HANGZHOU, China and SAN FRANCISCO, June 8, 2022 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on …See details»
先为达_杭州先为达生物科技股份有限公司 - sciwind.com.cn
The three lead candidates all congregate around GLP-1 receptor agonism, a mechanism that Sciwind reckons is relevant across fatty liver, obesity and diabetes. The new infusion marks …See details»
Sciwind Biosciences - Contacts, Employees, Board Members
Sciwind Biosciences has 4 current employee profiles, including Senior Vice President Martijn Fenaux. Contacts. Edit Contacts Section. Job Department. Protected Content. Banking and …See details»
Approach - Sciwind
Sciwind Biosciences is a fast-growing clinical-stage biopharmaceutical company focused on discovering and developing novel therapies to treat metabolic disease Why Metabolic …See details»
Sciwind Biosciences Acquires Global, Exclusive Rights to Develop …
Nov 30, 2021 Sciwind Biosciences is a clinical stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat metabolic disease. Its product …See details»
Sciwind Biosciences Announces Positive Topline Results from …
Jan 3, 2024 Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic diseases, today …See details»
Pipeline - Sciwind
Sciwind Biosciences owns global rights to all its pipeline products. Our Programs . XW003 . Injectable GLP-1 analogs are effective tools in managing type 2 diabetes, obesity, and have …See details»